Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-04 @ 4:43 PM
Study NCT ID:
NCT02187367
Status:
TERMINATED
Last Update Posted:
2019-09-10
First Post:
2014-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
Sponsor:
Bioven Europe
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-07
First Submit QC Date:
None
Study First Post Date:
2014-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-09
Last Update Post Date:
2019-09-10
Last Update Post Date Type:
ACTUAL